Mode
Text Size
Log in / Sign up
N/A Completed N=99 Randomized Single-blind Basic Science

Investigating the Neural Systems That Support the Beneficial Effects of Positive Emotion on Stress Regulation

Behavior
Source: ClinicalTrials.gov NCT04496258 ↗
Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcomePrimary: Mood Ratings (Pos) — 1.34; 1.04; .96; .83 units on a scale

Summary

For this study, community participants visited the PI's psychophysiology lab for a single experimental session. In this study, participants completed a brief mood measure, followed by a task training in which a research assistant described and gave examples of cognitive reappraisal in response to negative images. Participants were then randomly assigned to positive or neutral emotion induction conditions, delivered by virtual reality. Then, participants completed an event-related, picture-based cognitive reappraisal task for 23 minutes. Following the task, participants once again responded to a mood measure, completed post-task questionnaires (individual difference measures) and answered a series of questions regarding the task they completed, including difficulty of regulation, or any images that were personally relevant. The investigators predicted that the positive emotion induction would result in powerful effects on self-reported emotion, which may or may not interact with the cognitive reappraisal condition.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mood Ratings (Pos)
1.34; 1.04; .96; .83; .81; .77
PRIMARY
Means of Self-reported Emotion Ratings
2.68; 2.75; 5.09; 4.35; 5.33; 5.90
PRIMARY
Mood Induction Ratings
7.38; 4.81; 1.45; 2.52
SECONDARY
Debriefing of Instructions
41; 39
SECONDARY
Task Difficulty
2.41; 2.4; 4.55; 4.5
SECONDARY
Number of Participants With Full Task Compliance
41; 39
SECONDARY
Number of Participants Reviewed for Possible Prior Experience With the Reappraisal Task and/or Task Images
41; 39
SECONDARY
DWECK-E (Theries of Emotion Scale)
3.59; 3.46
SECONDARY
The Big Five Inventory-10 (BFI-1)
3.27; 2.99; 3.84; 3.42; 3.6; 3.65
SECONDARY
Brief Resilience Scale
2.83; 2.69
SECONDARY
Satisfaction With Life Scale
22.32; 21.31
SECONDARY
The Igroup Presence Questionnaire (IPQ)
3.73; 3.58; 3.79; 3.21; 2.39; 2.43
SECONDARY
Brief Cope
4.66; 4.49; 5.39; 5.59; 2.59; 3.08

Eligibility Criteria

Inclusion Criteria

  • Community members ages 18-55
  • Fluent in English
  • Without present psychotic symptoms

Exclusion Criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04496258). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search